000 01462 a2200361 4500
005 20250517111403.0
264 0 _c20180214
008 201802s 0 0 eng d
022 _a1536-4844
024 7 _a10.1097/MIB.0000000000000858
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcDaniel, Dylan K
245 0 0 _aEmerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
_h[electronic resource]
260 _bInflammatory bowel diseases
_c09 2016
300 _a2265-79 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aChemokines
_xmetabolism
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aI-kappa B Kinase
_xgenetics
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aInterleukin-1beta
_xgenetics
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aNF-kappa B p52 Subunit
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aEden, Kristin
700 1 _aRingel, Veronica M
700 1 _aAllen, Irving C
773 0 _tInflammatory bowel diseases
_gvol. 22
_gno. 9
_gp. 2265-79
856 4 0 _uhttps://doi.org/10.1097/MIB.0000000000000858
_zAvailable from publisher's website
999 _c26313844
_d26313844